Abstract
Sparse female enrollment in trials comparing 1st versus 2nd generation drug eluting stents (DES) may influence clinical decision making at time of percutaneous coronary intervention (PCI). We sought to examine trends in use and outcomes of 2nd generation DES across genders in a contemporary PCI
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
